Dieli-Conwright, Christina M. http://orcid.org/0000-0001-9093-7259
Nelson, Rebecca A.
Simon, Michael S.
Irwin, Melinda L.
Neuhouser, Marian L.
Reding, Kerryn W.
Crane, Tracy E.
Manson, JoAnn E.
Nassir, Rami
Shadyab, Aladdin H.
LaMonte, Michael
Qi, Lihing
Thomson, Cynthia A.
Kroenke, Candyce H.
Pan, Kathy
Chlebowski, Rowan T.
Mortimer, Joanne
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (N01WH22110)
National Cancer Institute (R25CA203650)
Article History
Received: 26 March 2021
Accepted: 31 January 2022
First Online: 5 February 2022
Declarations
:
: This investigation was approved by the Institutional Review Board for the WHI study at the Fred Hutchinson Cancer Center. Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Rowan Chlebowski is a consultant for Novartis, AstraZeneca, Genentech, Merck, Immunomedics, and Puma and received honorarium from Novartis and AstraZeneca. None of the other authors report any conflict of interest related to this study.